BMO Stock Recent News

Bank of Montreal remains my top Canadian bank pick, delivering 42% returns since 2023, thanks to its superior risk-reward profile and successful growth strategy. National Bank of Canada has emerged as another core Canadian bank holding, with disciplined expansion, strong capital, and standout revenue growth, especially after acquiring Canadian Western Bank. Royal Bank and CIBC are on my investment radar for future opportunities, while TD and Scotiabank face strategic and regulatory headwinds limiting near-term upside.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

Bank of Montreal has agreed to acquire independent wealth manager Burgundy Asset Management for 625 million Canadian dollars ($456.4 million) in shares.

Expands BMO's wealth management and financial planning capabilities focused on high-net-worth and ultra-high-net-worth individuals, families and institutions TORONTO , June 19, 2025 /PRNewswire/ - BMO (TSX:BMO) (NYSE:BMO) and Burgundy Asset Management Ltd. today announced the signing of a definitive agreement for BMO to acquire Burgundy Asset Management Ltd.

TORONTO , June 19, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company"), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that it has entered into two agreements that will strengthen its balance sheet, reduce debt, and support long-term growth: A non-binding agreement (the "Term Sheet") to amend and restate the Company's existing syndicated credit facility led by the Bank of Montreal ("BMO"), and An exchange agreement (the "Exchange Agreement") with Imperial Brands plc ("Imperial Brands") pursuant to which all amounts owing by the Company under the outstanding convertible debenture held by Imperial Brands (the "Debenture") will be settled in common shares of the Company ("Shares") and pre-funded warrants to purchase Shares. These transactions represent meaningful progress in the Company's ongoing efforts to strengthen its balance sheet.

BMO Capital analyst Kostas Biliouris downgraded Sarepta to Market Perform from Outperform with a price target of $70, down from $120. Elevidys treatment led to a second fatal case of acute liver failure in non-ambulatory patients, triggering management to look for potential changes to immunosuppressive regimen, the analyst tells investors in a research note. The firm believes the second death is part of Adeno-associated virus risk and Elevidys' benefit/risk remains favorable in ambulatory patients. However, BMO expects the news news to add pressure on Sarepta moving forward due to uncertainty around a potential withdrawal of Elevidys non-ambulatory approval. The company could also miss its Elevidys 2025 guidance or announce additional patient deaths, adds BMO.

Bank of Montreal has been paying uninterrupted dividends since 1829. The highlights of its business are its domestic retail & commercial bank and its wealth management unit. Its U.S. personal & business bank is a weak spot right now, partly due to elevated credit costs.

Squarepoint Ops LLC bought a new position in shares of Q32 Bio Inc. (NASDAQ:QTTB – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 19,009 shares of the company’s stock, valued at approximately $65,000. Squarepoint Ops LLC owned about 0.16% of Q32 Bio as of its most recent SEC filing. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in QTTB. Rhumbline Advisers grew its holdings in Q32 Bio by 1,164.3% during the fourth quarter. Rhumbline Advisers now owns 105,544 shares of the company’s stock worth $363,000 after acquiring an additional 97,196 shares during the period. Bleakley Financial Group LLC acquired a new stake in shares of Q32 Bio during the fourth quarter valued at $149,000. Raymond James Financial Inc. acquired a new stake in shares of Q32 Bio during the fourth quarter valued at $37,000. Cubist Syste

Not for distribution to U.S. news wire services or dissemination in the United States. PERTH, Australia, June 04, 2025 (GLOBE NEWSWIRE) -- FireFly Metals Ltd (ASX: FFM, TSX: FFM) (the “Company” or “FireFly”) has announced today that it has entered into an agreement with BMO Capital Markets, pursuant to which BMO Capital Markets has agreed to purchase, on a bought deal basis, 30,000,000 ordinary shares of the Company (the “Ordinary Shares”) at a price of C$0.86 (A$0.96) per Ordinary Share for gross proceeds of C$25.8 (approximately A$28.8)1 million (the “Canadian Offering”).

CINCINNATI--(BUSINESS WIRE)--American Financial Group, Inc. (NYSE: AFG) announced today that Carl H. Lindner III and S. Craig Lindner, Co-Chief Executive Officers, and Brian S. Hertzman, Senior Vice President & Chief Financial Officer, will participate in the 2025 BMO Capital Markets Insurance Summit on Thursday, June 12, 2025. While there will be no Company presentation, AFG will host several investor meetings. The investor material to be used in the meetings will be posted via a link unde.